HDAC9 and obesity disorder: The key finding from the present study is that acetate as HDAC inhibitor attenuates defective hypothalamic-adipose metabolic network in HFD-induced obesity and this beneficial effect of acetate is accompanied by elevated PPAR-γ and suppressed oxidative stress.